Global Cell-Free RNA Isolation & Extraction Kits Market is valued at US$ 41.55 Mn in 2023, and it is expected to reach US$ 123.94 Mn by 2031, with a CAGR of 14.90% during the forecast period of 2024-2031.
Global Cell-Free RNA Isolation & Extraction Kits Market is valued at US$ 41.55 Mn in 2023, and it is expected to reach US$ 123.94 Mn by 2031, with a CAGR of 14.90% during the forecast period of 2024-2031.
The cell-free RNA isolation & extraction kits market is being propelled by factors such as advances in molecular biology, individualized healthcare, and the need for quick and reliable diagnostic tests are driving the increasing demand for efficient and precise RNA extraction technologies. Furthermore, partnerships between pharmaceutical and biotech firms are also contributing to the growth of these markets. In addition, the market is expanding for several reasons, including an aging population, innovations in healthcare technology, patient education regarding non-invasive procedures, government funding, and rising knowledge of the benefits of these approaches to fuel market growth.
Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/1572
Recent Developments:
- In January 2024, Thermo Fisher Scientific introduced a revolutionary automation solution called GibcoTM Cell Therapy Systems CellmationTM Software. This software allows users to connect and integrate processes across several Thermo Fisher Scientific cell therapy devices, ensuring cGMP compliance.
- In Nov 2023, The FDA has approved Zymo Research’s DNA/RNA ShieldTM SafeCollectTM Saliva Collection Kit as a Class II medical device for the storage and stabilization of microbial nucleic acids. The product may be utilized as an In-vitro Diagnostic (IVD) device for saliva collection and transportation thanks to the FDA’s 510(k) authorization. For the field of molecular diagnostics, non-invasive saliva collection is essential because it provides comfortable and easy access to a multitude of genetic and biomolecular data, opening the door to revolutionary developments in disease detection and individualized healthcare.
- In June 2022, the Streck Viral Extraction Kit was commercialized with the help of Ceres Nanosciences, according to an announcement made by Streck. To streamline the process of isolating SARS-CoV-2 and Influenza A from clinical samples and reduce the amount of time that needs to be spent manually, Streck has created a viral extraction kit that uses Nanotrap technology.
List of Prominent Players in the Cell-Free RNA Isolation & Extraction Kits Market:
- Aline Biosciences
- Apostle Inc. (Apostle Sciences)
- Danagen-Bioted, S.L.
- Hoffmann-La Roche Ltd.
- JBS Science Inc.
- Norgen Biotek Corp
- PerkinElmer, Inc.
- Promega Corporation
- QIAGEN N.V.
- Streck, Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Zymo Research Corporation
Market Dynamics:
Drivers:
The growing need for improved methods of early diagnosis, monitoring, and individualized therapy is driven by the rising worldwide prevalence of chronic diseases and cancer. The prospect of cell-free RNA analysis is propelling isolation and extraction kits as a non-invasive diagnostic and therapy monitoring tool. In addition, the expansion of the cell-free RNA isolation & extraction kits business is propelled by spreading the word about cell-free RNA analysis and its possible diagnostic uses and advantages. Furthermore, the market expansion is fueled by rising investments in genetics, molecular diagnostics, and personalized medicine, spur innovation in cell-free RNA isolation & extraction kit services.
Challenges:
One major obstacle to using cell-free RNA isolation & extraction kits is their high cost and need for more availability. Due to the high cost of cell-free RNA isolation and extraction kits, specialized equipment, and reagents needed for downstream analysis, not all research institutes and smaller laboratories can afford them. As a result, their accessibility and acceptance are limited. Furthermore, the regulatory environment surrounding diagnostic tests that utilize cell-free RNA is intricate and differs across different regions. The time and effort needed to get regulatory permission can be substantial. The absence of uniform reimbursement procedures for these tests may also hinder market expansion.
Regional Trends:
The North American cell-free RNA isolation & extraction kits market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because the presence of well-established firms and their efforts to develop innovative quick filtration and isolation systems are the primary forces propelling the market expansion in the region. Furthermore, the industry is expanding faster due to the increased funding initiatives for biotechnology research. Furthermore, the forecast period is anticipated to expand due to various variables, including rising economic growth, extensive life sciences research, an increasing patient populace, helpful government initiatives, and many innovative biotech enterprises.
Segmentation of Cell-Free RNA Isolation & Extraction Kits Market-
Cell-Free RNA Isolation & Extraction Kits Market- By Application
- Oncology
- Prenatal Screening
- Metabolic Disorders
- Others
Cell-Free RNA Isolation & Extraction Kits Market- By End-Users
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Cell-Free RNA Isolation & Extraction Kits Market- By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Order the 180 Pages Detailed Report @ https://www.insightaceanalytic.com/buy-report/1572
Call: North America +1 551 226 6109 Email: diana.dsouza@insightaceanalytics.com